Certainly, our current understanding of the role of CARM1 in regulating proliferation and apoptosis in multiple myeloma through the p53 pathway is just beginning, and the related molecular mechanisms still need to be explored and studied in greater depth. This evidence concerns the gene CARM1 and AL amyloidosis.